Mark Lappe is Chief Executive Officer and Chairman of the Board of Directors of Inhibrx Biosciences, Inc. (INBX). The company reported total compensation of $2,892,473 for fiscal year 2025.
| Salary | $695,250 |
|---|---|
| Bonus | $1,700,000 |
| Stock awards | $0 |
| Option awards | $0 |
| Non-equity incentive plan | $479,723 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $17,500 |
| Total | $2,892,473 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Inhibrx Biosciences, Inc. filed April 23, 2026, accession 0002007919-26-000014.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | Chief Executive Officer and Chairman of the Board of Directors | $695,250 | $1,700,000 | $0 | $0 | $479,723 | $0 | $17,500 | $2,892,473 |
| FY2024 | Chief Executive Officer and Chairman of the Board of Directors | $695,250 | — | — | $3,573,408 | $417,150 | — | $5,975 | $4,691,783 |
Totals as disclosed in each year's own compensation disclosure for Inhibrx Biosciences, Inc..
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Mark Lappe this page | Chief Executive Officer and Chairman of the Board of Directors | $2,892,473 |
| David Matly | President | $1,435,940 |
| Kelly Deck | Chief Financial Officer | $923,696 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Inhibrx Biosciences, Inc. compensation brief.
Mark Lappe's compensation sits inside Inhibrx Biosciences, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.